AIBOTICS, INC. Files Q2 2025 10-Q Report
Ticker: AIBT · Form: 10-Q · Filed: Aug 19, 2025 · CIK: 1763329
| Field | Detail |
|---|---|
| Company | Aibotics, INC. (AIBT) |
| Form Type | 10-Q |
| Filed Date | Aug 19, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001, $350,000, $0, $498 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, company-information
TL;DR
AIBOTICS, INC. filed their Q2 2025 10-Q. All good.
AI Summary
AIBOTICS, INC. filed its quarterly report for the period ending June 30, 2025. The company, formerly known as Mycotopia Therapies, Inc. and 20/20 Global, Inc., is involved in the medicinal chemicals & botanical products sector. Their principal business address is in Heyburn, ID.
Why It Matters
This filing provides investors with an update on AIBOTICS, INC.'s financial performance and operational status for the second quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new information.
Key Numbers
- 20250630 — Reporting Period End Date (Indicates the end of the fiscal quarter for this filing.)
- 20250819 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- AIBOTICS, INC. (company) — Filer of the 10-Q
- Mycotopia Therapies, Inc. (company) — Former name of AIBOTICS, INC.
- 20/20 Global, Inc. (company) — Former name of AIBOTICS, INC.
- 20250630 (date) — End of the reporting period
- 20250819 (date) — Filing date
FAQ
What is the primary business of AIBOTICS, INC.?
AIBOTICS, INC. is classified under MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].
When was the company formerly known as Mycotopia Therapies, Inc.?
The name change from Mycotopia Therapies, Inc. to AIBOTICS, INC. occurred on 20210519.
What is the state of incorporation for AIBOTICS, INC.?
AIBOTICS, INC. is incorporated in Nevada (NV).
What is the fiscal year end for AIBOTICS, INC.?
The fiscal year end for AIBOTICS, INC. is December 31 (1231).
What is the business address of AIBOTICS, INC.?
The business address is 480 22ND STREET, HEYBURN, ID 83336.
Filing Stats: 4,535 words · 18 min read · ~15 pages · Grade level 15.7 · Accepted 2025-08-19 15:51:48
Key Financial Figures
- $0.001 — g) of the Act: Common Stock, Par Value $0.001 (Title of class) Indicate by check m
- $350,000 — de for: (i) 20/20 Global's purchase for $350,000 in cash of all of the outstanding stock
- $0 — e 30, 2025, and 2024, respectively, and $0 and $498 for the six months ended June
- $498 — 025, and 2024, respectively, and $0 and $498 for the six months ended June 30, 2025,
Filing Documents
- tpia-20250630_10q.htm (10-Q) — 556KB
- tpia_ex31z1.htm (EX-31.1) — 8KB
- tpia_ex32z1.htm (EX-32.1) — 4KB
- 0001096906-25-001375.txt ( ) — 2897KB
- tpia-20250630_cal.xml (EX-101.CAL) — 19KB
- tpia-20250630_def.xml (EX-101.DEF) — 91KB
- tpia-20250630_lab.xml (EX-101.LAB) — 155KB
- tpia-20250630_pre.xml (EX-101.PRE) — 150KB
- tpia-20250630.xsd (EX-101.SCH) — 35KB
- tpia-20250630_10q_htm.xml (XML) — 414KB
—Financial Information
Part I—Financial Information 1
Financial Statements
Financial Statements 4 Condensed Consolidated Balance Sheets as of June 30, 2025 (unaudited) and December 31, 202 4 4 Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) 5 Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit for the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) 6 Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024 (unaudited) 7 Notes to the Unaudited Condensed Consolidated Financial Statements 8 2
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 3
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 20 4
Controls and Procedures
Controls and Procedures 20
—Other Information
Part II—Other Information 6 Exhibits 21
–FINANCIAL INFORMATION
PART I–FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS AIBOTICS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS June 30, December 31, 2025 2024 (unaudited) ASSETS CURRENT ASSETS: Cash $ 242,179 $ 185,097 Total Current Assets 242,179 185,097 NON-CURRENT ASSETS: Intangible assets, net 943,431 1,271,898 TOTAL ASSETS $ 1,185,610 $ 1,456,995 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES: Accounts payable and accrued expenses $ 474,076 $ 283,341 Accrued interest 417,360 399,822 Accrued expenses – related party 958,000 864,000 Convertible note payable, net of debt discount 1,351,884 1,100,000 Notes payable – related party 165,000 165,000 Shares to be issued 2,027,600 2,039,600 TOTAL LIABILITIES 5,393,920 4,851,763 Commitments and contingencies (Note 9 – Commitments and Contingencies) - - MEZZANINE EQUITY Series B Preferred stock, $ 0.001 par value; 1,500,000 shares authorized at June 30, 2025 and December 31, 2024; 200 shares issued and outstanding as of June 30, 2025 and December 31, 2024; liquidation preference of $ 0 as of June 30, 2025 and December 31, 2024 200 200 STOCKHOLDERS' DEFICIT Preferred stock, 5,000,000 shares authorized: Series A Preferred Stock, $ 0.001 par value, 0 shares authorized at June 30, 2025 and December 31, 2024; 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively - - Common stock, $ 0.001 par value; 467,000,000 shares authorized at June 30, 2025 and December 31, 2024; 51,625,089 and 39,990,903 shares issued and outstanding as of June 30, 2025, and December 31, 2024, respectively 51,625 39,991 Additional paid in capital 7,626,667 7,374,297 Accumulated deficit ( 11,886,802 ) ( 10,809,256 ) TOTAL STOCKHOLDERS' DEFICIT ( 4,208,310 ) ( 3,394,768 ) TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT $ 1,185,610 $ 1,456,995 The accompanying notes are an integral part of these con